CGC - Canopy Growth Corporation
NEXT EARNINGS:
May 29, 2026
EPS Est: $-0.01
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$14.47
DETAILS
HIGH:
$27.85
LOW:
$8.00
MEDIAN:
$11.02
CONSENSUS:
$14.47
UPSIDE:
1136.75%
Market Cap:
601.99M
Volume:
7,718,168
Avg Volume:
28,219,490
52 Week Range:
0.77-2.38
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
2.40
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
1,029
IPO Date:
2014-04-07
EPS (TTM):
-5.53
P/E Ratio:
-0.24
Revenue (TTM):
269.00M
Total Assets:
917.70M
Total Debt:
348.40M
Cash & Equiv:
113.81M
Rev Growth (5Y):
-7.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-63.5%
Debt/Equity:
0.72
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-06 | $-0.10 | $-0.03 | -233.3% | $90.4M | $73.8M | +22.4% |
| 2025-11-07 | $-0.01 | $-0.11 | +90.9% | $66.7M | $71.0M | -6.1% |
| 2025-08-08 | $-0.14 | $-0.15 | +6.7% | $52.8M | $69.6M | -24.2% |
| 2025-05-30 | $-0.94 | $-0.10 | -840.0% | $44.5M | $67.1M | -33.7% |
| 2025-02-07 | $-0.76 | $-0.38 | -100.0% | $51.9M | $72.0M | -27.9% |
| 2024-11-08 | $-0.95 | $-0.38 | -150.0% | $46.6M | $47.2M | -1.4% |
| 2024-08-09 | $-0.37 | $-0.31 | -19.4% | $48.4M | $50.7M | -4.5% |
| 2024-05-30 | $-0.28 | $-0.33 | +15.2% | $53.6M | $53.1M | +1.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 269.00M | 297.15M | 333.25M | 475.70M | 546.65M | 398.77M | 226.34M | 77.95M | 39.90M | 12.70M | 1.15M | 0 |
| Net Income | (598.12M) | (657.27M) | (3.28B) | (310.04M) | (1.74B) | (1.32B) | (670.09M) | (54.13M) | (16.61M) | (3.50M) | (8.93M) | (932,925) |
| EPS | -5.53 | -6.47 | -70.70 | -7.70 | -4.45 | -3.96 | -1.99 | -0.31 | -0.14 | -0.05 | -0.30 | -0.93 |
| Total Assets | 917.70M | 1.30B | 2.44B | 5.61B | 6.82B | 4.82B | 8.73B | 1.44B | 677.61M | 143.36M | 47.77M | 5.15M |
| Total Debt | 348.40M | 668.00M | 1.41B | 1.64B | 1.72B | 439.68M | 945.98M | 8.42M | 10.33M | 4.02M | 1.92M | 40,417 |
| Cash & Equivalents | 113.81M | 170.30M | 667.69M | 776.00M | 1.15B | 915.57M | 2.48B | 322.56M | 101.80M | 15.40M | 21.45M | 2.09M |
| Operating Cash Flow | (165.75M) | (281.95M) | (557.55M) | (545.81M) | (465.73M) | (772.63M) | (520.51M) | (81.51M) | (27.09M) | (12.45M) | (9.75M) | (1.38M) |
| Free Cash Flow | (177.03M) | (285.95M) | (568.00M) | (593.92M) | (639.87M) | (1.49B) | (1.20B) | (259.68M) | (56.62M) | (23.16M) | (21.71M) | (2.43M) |
| FCF per Share | -1.65 | -2.81 | -12.25 | -15.18 | -1.71 | -4.27 | -3.57 | -1.46 | -0.48 | -0.30 | -0.73 | -2.43 |
| Book Value | 487.21M | 500.37M | 758.43M | 3.58B | 3.48B | 3.43B | 6.95B | 1.16B | 614.77M | 123.78M | 41.41M | 3.83M |
| Cash & ST Investments | 131.47M | 203.46M | 773.22M | 1.37B | 2.32B | 1.40B | 4.51B | 322.56M | 101.80M | 15.40M | 21.45M | 2.09M |
| ROC Equity | -1.23 | -1.31 | -4.32 | -0.09 | -0.50 | -0.38 | -0.10 | -0.05 | -0.03 | -0.03 | -0.22 | -0.24 |